Great Lakes Advisors LLC Sells 5,837 Shares of Encompass Health Co. (NYSE:EHC)

Great Lakes Advisors LLC trimmed its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 2.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 245,436 shares of the company's stock after selling 5,837 shares during the quarter. Great Lakes Advisors LLC owned 0.24% of Encompass Health worth $22,666,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. CIBC Asset Management Inc increased its stake in Encompass Health by 3.5% in the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company's stock worth $286,000 after acquiring an additional 100 shares during the last quarter. Miracle Mile Advisors LLC boosted its holdings in shares of Encompass Health by 3.0% in the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company's stock worth $354,000 after purchasing an additional 112 shares in the last quarter. US Bancorp DE boosted its holdings in shares of Encompass Health by 9.6% in the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock worth $127,000 after purchasing an additional 121 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after purchasing an additional 137 shares in the last quarter. Finally, SPC Financial Inc. boosted its holdings in shares of Encompass Health by 0.3% in the 4th quarter. SPC Financial Inc. now owns 45,077 shares of the company's stock worth $4,163,000 after purchasing an additional 154 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Down 2.2 %

Shares of NYSE:EHC opened at $96.98 on Wednesday. The stock has a fifty day simple moving average of $97.18 and a two-hundred day simple moving average of $96.90. The stock has a market capitalization of $9.77 billion, a price-to-earnings ratio of 21.74, a PEG ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 12-month low of $74.27 and a 12-month high of $104.55. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Remove Ads

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, research analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Tuesday, April 1st. Encompass Health's dividend payout ratio is currently 15.25%.

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares of the company's stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 2.10% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on EHC shares. Barclays upped their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. William Blair reiterated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. KeyCorp increased their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. Finally, StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Ten analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.